How Much Tart Cherry for Gout? A Dosage Breakdown

There is no single universally agreed-upon dose of tart cherry for gout, but clinical trials have typically used daily amounts in the range of 8 to 16 ounces of tart cherry juice, 60 to 120 milliliters of tart cherry juice concentrate, or around 500 milligrams of tart cherry extract in capsule form. The evidence for uric acid reduction is real but modest, and the details around dose, form, and duration matter more than most supplement labels suggest.

What Doses Have Been Tested in Human Trials

Across the handful of randomized controlled trials that exist, the dosing protocols vary widely. One trial in overweight and obese adults used 240 mL (about 8 ounces) of 100% tart cherry juice daily for four weeks and found a roughly 19% drop in plasma urate compared to a placebo group, whose levels actually crept upward over the same period.¹ A pharmacokinetic study in people with gout used tart cherry juice concentrate at either 60 mL or 120 mL per dose, tracking how the key anthocyanin compounds reached the bloodstream in a dose-dependent way.² And a recent trial testing capsule form used 500 mg of tart cherry extract daily for four weeks, reporting a substantial 37% reduction in urate and a 23% reduction in a marker of inflammation called C-reactive protein.³

A 2025 meta-analysis pooled data from four randomized trials involving 392 participants and found that tart cherry intake was linked to a modest overall reduction in serum uric acid, though the results varied considerably between studies.⁴ “Modest” is the honest word here. The effect is measurable, but it is not comparable to what pharmaceutical urate-lowering drugs achieve. If your uric acid is significantly elevated, tart cherry on its own is unlikely to bring it into the normal range.

Why a Single Dose Probably Will Not Help

One of the more consistent findings in the research is that taking tart cherry once, or even a few times, does not appear to move the needle on uric acid. A randomized crossover trial found no statistically significant effect of tart cherry juice on serum uric acid, urinary uric acid, or C-reactive protein when comparing a single dose against a placebo. The researchers noted that uric acid levels naturally fluctuate throughout the day, and these normal diurnal swings may have been mistaken for a cherry effect in earlier studies that lacked a control group.⁵ A separate trial confirmed that acute administration of tart cherry extract did not alter urate or inflammation markers, even though the same extract did produce significant reductions when taken daily over four weeks.³

The takeaway is straightforward: if you’re drinking a glass of tart cherry juice the moment you feel a flare coming on and expecting quick relief, the evidence does not support that approach. The studies showing benefit have all used daily supplementation over at least four weeks. Tart cherry appears to work gradually, not as a rescue measure.

How Tart Cherry Lowers Uric Acid

The most commonly cited mechanism is inhibition of xanthine oxidase, the enzyme your body uses to convert purines into uric acid. This is the same enzyme that the prescription gout drug allopurinol targets. Animal studies have confirmed that tart cherry juice does inhibit this enzyme in liver tissue.⁶ Lab work on 21 sour cherry cultivars showed that certain varieties inhibit xanthine oxidase more effectively than others, suggesting the specific cherry variety matters.⁷

But xanthine oxidase inhibition may not be the only pathway involved. A rat study found something unexpected: at a lower dose, tart cherry powder reduced uric acid primarily by affecting adenosine deaminase activity, a different enzyme earlier in the purine breakdown chain, rather than xanthine oxidase. Interestingly, a higher dose in the same study did not reduce uric acid levels as effectively, though it did help protect the kidneys.⁸ This complicates the picture. More is not always better, and the mechanism may shift depending on the dose.

The Anti-Inflammatory Side of Things

Uric acid reduction is only part of the gout story. Gout attacks happen when urate crystals trigger an intense inflammatory response in the joint, and tart cherry appears to act on that inflammatory cascade too. A review of cherry research noted that cherries have anti-inflammatory effects on multiple inflammatory signals, and that these properties could help with both the acute flare and the chronic joint damage associated with repeated attacks.⁹

Mouse studies have given a more specific picture. When tart cherry juice concentrate was given to mice that had urate crystals injected into their joints, the inflammatory response measured by a key signaling pathway was cut roughly in half compared to untreated mice, and tissue samples showed less immune cell infiltration into the joint space.¹⁰ A separate animal study found that tart cherry extract reduced neutrophil recruitment to the inflamed area and decreased levels of inflammatory cytokines by suppressing the same signaling pathway and inhibiting an inflammasome involved in crystal-driven gout inflammation.¹¹

This dual action, lowering uric acid while also dampening the inflammatory response to crystals, is what makes tart cherry an interesting complement to standard treatment. Standard urate-lowering drugs do not directly address the inflammatory component of a flare, which is why colchicine or anti-inflammatory medications are typically prescribed alongside them. Tart cherry potentially works on both fronts, though obviously at much lower potency than a drug.

Does Cherry Intake Actually Prevent Gout Flares

The strongest piece of evidence linking cherry consumption to real-world gout outcomes comes from a study that tracked over 600 people with confirmed gout for a year, logging their diet and gout attacks in real time. Cherry intake over a two-day period was associated with a 35% lower risk of a gout attack compared to periods with no cherry intake. Cherry extract was associated with a 45% reduced risk. The protective effect seemed to increase up to about three servings over two days but did not improve with even higher amounts.¹² A serving in that study was about half a cup of fresh cherries or one tablespoon of cherry extract.

That study did not distinguish between sweet and tart cherries, and it was observational, meaning it can show a pattern but cannot definitively prove that the cherries caused the reduction. Still, it remains the most-cited evidence for cherry use in gout, and the dose-response curve topping out at three servings is often used as a practical benchmark: eating a handful of cherries a couple of times a day may help, but eating a pound of them will not necessarily help more.

A prospective trial tested a “TaCCi” mixture that combined tart cherry supplementation with citrate and compared it against standard sodium bicarbonate urine alkalinization in gout patients. The tart cherry group experienced fewer flares and had lower inflammatory markers at 12 weeks, though all groups saw similar reductions in serum uric acid because all were also receiving standard urate-lowering therapy.¹³ This suggests that tart cherry’s benefit during active treatment may come primarily from its anti-inflammatory effects rather than from additional uric acid lowering.

The Product Quality Problem You Should Know About

Here is where tart cherry supplements get genuinely frustrating. A review of how tart cherry products are characterized in research studies found that supplementation protocols have been highly variable across the literature, and the dose of bioactive compounds used has often been poorly reported. The total polyphenol content across studies ranged from 143 to 2,140 mg per day, while the anthocyanin content ranged from 15 to 547 mg per day.¹⁴ That is an enormous range. Two products both labeled “tart cherry extract” might deliver ten times or one-tenth the bioactive compounds of each other.

The review also pointed out that different labs use different analytical methods to measure polyphenol and anthocyanin content, making cross-study comparison unreliable. In practical terms, this means the bottle you buy at your local supplement store might contain a product nothing like what was used in the clinical trial you read about. Unlike pharmaceutical drugs, supplements are not required to demonstrate bioequivalence. The most reliable approach, if you can manage it, is to use the same specific product that was tested in a study, or at minimum choose products that report their anthocyanin content on the label and use Montmorency tart cherries, the variety used in the majority of published trials.

Juice, Concentrate, Capsule, or Whole Fruit

Each form has practical tradeoffs that go beyond just the dose of active compounds.

Whole tart cherries: Hard to find fresh outside of a short summer season. Frozen tart cherries are more accessible. The gout flare study used servings of about 10 to 12 cherries, consumed a few times a day.
Tart cherry juice (100%): The easiest to find in grocery stores. Trials have used around 8 ounces daily. The sugar content is significant, around 25 grams per cup, which matters if you have metabolic concerns since fructose can itself raise uric acid levels.
Tart cherry juice concentrate: Doses tested include 30 to 120 mL per day, often diluted in water. Contains the same sugars as juice but in smaller volume, so total sugar intake is somewhat lower.
Capsules and extracts: Typically 500 to 1,000 mg per day. Avoid the sugar issue entirely. The 500 mg extract dose produced the largest percentage reduction in uric acid of any form tested in the studies reviewed here, though it was in healthy adults rather than gout patients specifically.

The sugar consideration deserves emphasis. Fructose is metabolized in a way that generates uric acid as a byproduct. Drinking large amounts of tart cherry juice every day could theoretically work against you if the fructose load outweighs the urate-lowering benefit of the anthocyanins. This is one reason researchers have moved toward testing concentrates and capsule extracts at lower volumes.

Why Your Results May Differ from Someone Else’s

Individual variation in response to tart cherry is likely influenced by gut bacteria. The polyphenols in tart cherries are not all absorbed directly in your small intestine. A significant portion passes into the colon, where gut microbes break them down into various smaller compounds. Research has confirmed that gut bacteria metabolize cherry polyphenols into phenolic acids, and that different people’s microbiomes produce different metabolite profiles from the same starting material.¹⁵ The researchers specifically noted that individual “metabotypes,” meaning distinct patterns of microbial metabolism, need to be considered when studying cherry consumption and health.

This could explain some of the inconsistency in trial results. If your gut microbiome efficiently converts cherry anthocyanins into bioactive metabolites, you might get a meaningful uric acid reduction. If it doesn’t, you might get very little benefit from the same dose. There is currently no practical way to test for this, but it is worth knowing that the person who swears by tart cherry juice and the person who tried it and noticed nothing may both be telling the truth about their experience.

Tart Cherry as a Complement, Not a Replacement

Roughly a quarter of gout patients report trying cherries or cherry products to manage their condition.⁹ That is a large share of patients making a dietary choice based on what is still a relatively thin body of evidence. The meta-analysis found a statistically significant but modest effect, and the trial that showed the most impressive uric acid reduction (37%) was conducted in healthy adults, not in gout patients with chronically elevated levels.⁴ The TaCCi trial, which did enroll gout patients on medication, found that tart cherry supplementation added benefit in terms of fewer flares and lower inflammation but did not lower uric acid beyond what the standard drug therapy was already achieving.¹³

If you already take allopurinol or febuxostat and have your uric acid under control, tart cherry’s value is likely in its anti-inflammatory properties and possibly in reducing flare frequency, not in further urate lowering. If you’re trying to manage gout without medication, tart cherry alone is unlikely to be sufficient for most people whose uric acid is well above target. It sits most comfortably in the category of “reasonable addition to a broader management plan,” alongside hydration, dietary purine reduction, and weight management.

Timing and Practical Dosing Strategy

Given that chronic intake over weeks appears to matter while single doses do not, the practical advice is consistent daily use. The specific time of day does not seem to matter based on the available data, but splitting doses might make sense from a pharmacokinetic standpoint. The anthocyanin that reached the highest plasma concentrations in the pharmacokinetic study, cyanidin-3-glucosylrutinoside, appeared in a dose-dependent pattern, and concentrate doses were tested at 60 mL and 120 mL.² Anthocyanins have relatively short half-lives in the bloodstream, so spreading intake across the day rather than taking everything at once could help maintain steadier exposure, though no trial has directly compared split versus single daily dosing.

A reasonable starting protocol based on the weight of the evidence would be one of the following, maintained daily for at least four weeks before assessing whether it is helping:

Juice: 8 ounces of 100% tart cherry juice (not a blend or cocktail) once daily
Concentrate: 30 to 60 mL of tart cherry juice concentrate, diluted in water, once or twice daily
Capsule extract: 480 to 500 mg of tart cherry extract once daily

If you’re using juice, watch the sugar. An 8-ounce glass daily adds around 25 grams of sugar and 120 or so calories. For someone already managing weight or blood sugar, capsules sidestep this issue entirely. And remember the flare study’s finding that benefit plateaued at roughly three servings of cherries over two days. Doubling or tripling these doses in hopes of a bigger effect is not supported by the evidence and, based on the animal study that found higher doses less effective for uric acid reduction, could potentially be counterproductive.

Which Cherry Variety Matters

Most published human trials use Montmorency tart cherries, the dominant commercial variety in North America. But the xanthine oxidase inhibition study that tested 21 different sour cherry cultivars found significant differences in potency between varieties, with three cultivars standing out as markedly better inhibitors than the rest.⁷ European sour cherries like the Morello type, commonly available in some countries, belong to the same species but may have different anthocyanin profiles. If your tart cherry product does not specify the cultivar, you are assuming it behaves like the Montmorency used in trials, which may or may not be true.

Sweet cherries, like Bing and Rainier varieties, are a different species entirely and have lower anthocyanin concentrations. The flare reduction study did include sweet cherry consumption and still found a benefit, so sweet cherries are not useless, but the uric acid lowering evidence specifically involves tart cherries. If your goal is uric acid reduction, tart is the better bet. If your local store only carries sweet cherries, they still offer some anti-inflammatory polyphenols, just less of the specific compounds that have been studied for gout.